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peak might not be of the same virus (83.5%). Furthermore, 27.8% of all
respondents expected that the additional vaccination could weaken the
efficacy of previous vaccinations; 51.3% was concerned about side
Abbreviations: AOR =
organization.
vaccine becomes a co
is identified during the
chance to incorporate
Editor: Barry Margulies.
Received: November 6, 2015; revised: February 11, 2016; accepted: March
21, 2016.
From the School of Public Health and Primary Care (MCSW, SYSW);
Department of Paediatrics (EASN, FWTC, TFL); Department of Anesthe-
sia and Intensive Care (CL); Department of Medicine and Therapeutics
(NL, KWC); Department of Microbiology (MCWC, PKSC); Accident and
Emergency Medicine Academic Unit (THR); Department of Obstetrics and
Gynaecology, Faculty of Medicine, Chinese University of Hong Kong
(THC); Department of Pathology (Microbiology), Queen Elizabeth
Hospital (CKCL); and Department of Pathology (Microbiology), Princess
Margaret Hospital (BL), Hong Kong SAR.
Correspondence: Paul K.S. Chan, Department of Microbiology, Faculty of
Medicine, The Chinese University of Hong Kong, 1/F, Lui Che Woo
Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan
Shing Street, Shatin, NT, Hong Kong SAR
(e-mail: paulkschan@cuhk.edu.hk).
PKSC andMCSW designed the study, interpreted the findings, and wrote the
manuscript; EASN, CL, and MCWC developed questionnaire and
logistic planning; NL, KWC, THR, FWTC, SYSW, CKCL, BL, THC,
and TFL collected and analyzed the survey data. All authors, external and
internal, had full access to all of the data (including statistical reports and
tables) in the study and can take responsibility for the integrity of the data
and the accuracy of the data analysis.
The authors have no funding and conflicts of interest to disclose.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
This is an open access article distributed under the Creative Commons
Attribution-NoDerivatives License 4.0, which allows for redistribution,
commercial and non-commercial, as long as it is passed along unchanged
and in whole, with credit to the author.
ISSN: 0025-7974
DOI: 10.1097/MD.0000000000003359
Medicine  Volume 95, Number 19, May 2016H. Rainer, MD
r K.C. Lai, MBosco Lam, MBBS, Tak Hong Cheung, MD, T
Abstract: We evaluated the acceptability of an additional ad hoc
influenza vaccination among the health care professionals following
seasons with significant antigenic drift.
Self-administered, anonymous surveys were performed by hard
copy questionnaires in public hospitals, and by an on-line platform
available to all healthcare professionals, from April 1st to May 31st,
2015. A total of 1290 healthcare professionals completed the ques-
tionnaires, including doctors, nurses, and allied health professionals
working in both the public and private systems.
Only 31.8% of participating respondents expressed an intention to
receive the additional vaccine, despite that the majority of them agreed
or strongly agreed that it would bring benefit to the community (88.9%),
save lives (86.7%), reduce medical expenses (76.3%), satisfy public
expectation (82.8%), and increase awareness of vaccination (86.1%).
However, a significant proportion expressed concern that the vaccine
could disturb the normal immunization schedule (45.5%); felt uncertain
what to do in the next vaccination round (66.0%); perceived that the
summer peak might not occur (48.2%); and believed that the summerg, MD, Christophe BChB,
g Fan Leung, MD, and Paul K.S. Chan, MD
effects; and 61.3% estimated that there would be a low uptake rate. If the
supply of vaccine was limited, higher priority groups were considered to
include the elderly aged 65 years with chronic medical conditions
(89.2%), the elderly living in residential care homes (87.4%), and long-
stay residents of institutions for the disabled (80.7%). The strongest
factors associated with accepting the additional vaccine included
immunization with influenza vaccines in the past 3 years, higher
perceived risk of contracting influenza, and higher perceived severity
of the disease impact.
The acceptability to an additional ad hoc influenza vaccination was
low among healthcare professionals. This could have a negative impact
on such additional vaccination campaigns since healthcare professionals
are a key driver for vaccine acceptance. The discordance in perceived
risk and acceptance of vaccination regarding self versus public deserves
further evaluation.
(Medicine 95(19):e3359)adjusted odds ratios, WHO = world healthINTRODUCTION
G lobally, influenza is a highly contagious and seriousrespiratory disease that leads to significant morbidity
and mortality. Its annual attack rate is estimated at 5% to
10% in adults and 20% to 30% in children, resulting in 3 to
5 million cases of severe illness with an annual death toll of
250,000 to 500,000.1 Influenza vaccination may reduce the
number of hospital admissions by 25% to 39%, and has been
shown to reduce overall mortality by 39% to 75%.2 The World
Health Organization (WHO) has identified priority at-risk
groups for influenza immunization, which include pregnant
women, children aged between 6 months and 5 years, persons
older than 65 years, patients with chronic medical conditions,
and health care workers.3 To achieve the best possible match
between vaccine and circulating strains, the WHO Collaborat-
ing Centres for the Global Influenza Surveillance and Response
System regularly performs antigenic and genetic analyses,4 and
make recommendations for vaccine strains twice a year for the
Northern and Southern Hemisphere, respectively.
Influenza A (H3N2) is the most commonly identified
subtype with the most frequent antigenic drift.5 When signifi-
cant antigenic drift occurs, the protection of mismatchedncern. When the newly drifted variant
Northern Hemisphere winter, there is a
the new strain into the coming Southern
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(1)Hemisphere vaccine. Countries with multiple influenza peaks
can theoretically administer an additional dose of the new
vaccine to reduce disease in the subsequent peak season. In
subtropical regions, there are often 2 seasonal peaks of influ-
enza within a year.6,7 For instance, in Hong Kong, the influenza
seasons are January to March and June to August,8 and the
government has opted to offer the Northern Hemisphere vaccine
once a year in October to December. In early 2015, a heavy flu
season occurred due to the newly drifted influenza strain, A
H3N2 Switzerland that had not been included in the Northern
Hemisphere vaccine. In view of the reduced level of protection
as reported elsewhere,9 the Hong Kong Government decided to
place an additional procurement of Southern Hemisphere
vaccine that contains the new virus strain. Given the limited
supply, the additional dose of vaccine was only offered to
selected groups. Vaccine was planned to be administered in
May to prepare for the summer peak expected in June to August
of 2015.
Nevertheless, the success of such a programme involving
administration of an additional dose of vaccine will depend on
many factors, one of which includes the attitude and perception
of healthcare professionals who are a key driver of vaccination.
In a previous local study, which investigated the community
responses and preparedness for a possible epidemic of H1N1
when the pandemic level was already phase 5, the public did not
perceive a high likelihood of having a real outbreak, nor did
they regard the infection as threatening.10 In another survey
performed in Hong Kong that evaluated the acceptability of
prepandemic influenza vaccination among healthcare workers,
the willingness to accept the vaccine was low11 – with many
concerned about the side effects and doubted the efficacy of the
additional vaccine. However, healthcare workers are in general
at higher risk for influenza infection than the general public,12
due to their exposure at their workplace and close proximity to
patients.13,14
The primary objective of this study was to evaluate the
acceptability and perception of receiving the additional vaccine
among healthcare professionals, and the factors associated with
their willingness to receive the vaccination. In addition, we also
assessed their preference and perceived target groups which
should deserve a higher priority for receiving the additional
vaccine.
METHODS
The survey was conducted from March, 2015 to April,
2015. As of March 2015, more than 300 deaths and numerous
severe cases in Hong Kong had been reported by the Govern-
ment, and a plan to purchase 100,000 additional Southern
Hemisphere vaccines was announced in March, 2015, but the
details of the target groups were not yet decided during the
period of this survey. The Southern Hemisphere vaccine con-
tains A/California/7/2009 (H1N1) pdm09-like virus, A/Switzer-
land/9715293/2013(H3N2)-like virus, and B/Phuket/3073/
2013-like virus. The public, including the healthcare workers,
were informed of this plan via the media.15
Ethics, Consent, and Permissions
The study was approved by the Survey and Behavioural
Research Ethics Committee of the Chinese University of Hong
Kong. The surveys were anonymous and no written consent was
Wong et alrequired as completion of the survey implied consent. No
individual information could be identified and all findings were
reported as aggregate data.
2 | www.md-journal.comSurvey Invitation
We recruited healthcare professionals in both public and
private hospitals and clinics. The survey consisted of both hard
copy and web-based online version of the questionnaire. We
distributed the surveys to various departments in major public
hospitals including pediatrics, medicine and pathology, emer-
gency medicine, internal medicine, intensive care, and obste-
trics and gynecology via hard copies. Questionnaires were also
distributed during seminars for continuous medical education.
E-mail invitations to the online platform were sent to members
of the Hong Kong College of Family Physicians and the
Provisional Hong Kong Academy of Nursing, and all doctors
who have registered their practice information on the web and
provided e-mail addresses (http://hkdoctors.org/). Up to 2
reminders were sent on a 2-weekly basis after the 1st invitation
was issued. Hard copy versions were sent to healthcare pro-
fessionals in the public sector, whereas electronic invitations
were sent to prospective study participants in the private sector.
The ratio of hard copies and e-invitations was 2.2:1 in the
present study.
Survey Instruments
We designed a self-administered, anonymous question-
naire based on the survey items previously published by our
research team.11 An expert panel consisting of microbiologists,
pediatricians, epidemiologists, public health practitioners, and
family physicians constructed and validated the survey items.
The survey was subsequently pilot-tested in 15 healthcare
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emic, public, and private). The questionnaire consisted of(acad
6 sections, including:
Demographics, patient contact, and history of seasonal
influenza vaccination in the past 3 years;
Opinions on the new version of Southern Hemisphere(2)
vaccine which contained the new virus ‘‘A H3N2
Switzerland’’ that caused most of the infections in early
2015 in Hong Kong;(3) Their recommendation on the groups of people who should
be accorded higher priority to receive the new vaccine if
the Government had limited doses;
Intention to accept the additional vaccine;(4)
(5) Perception of risk and seriousness of the H3N2 influenza
infection, as well as the effectiveness and safety of the
influenza vaccine in general; and.(6) Their opinions on compulsory vaccination and deployment
of duties for unvaccinated staff during the influenza
season.
The full version of the survey instrument could be found
from Appendix I. The respondents could choose ‘‘no opinions’’
in some of the survey items.
Statistical Analyses
We performed descriptive statistics with proportions. The
response rates for public and private healthcare settings were
obtained by the number of complete surveys sent to the
researchers divided by the total number of the surveys sent
to the potential study participants. Using a methodology similar
to Chor et al,11 we analyzed the univariate association betweentention to accept the additional vaccine and the following
bles: age (30 vs>30 years), sex, specialty, job title, years
rk in health services, number of patient contacts per week,
pyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Participant Characteristics (N¼1290)
n %
Age, years
30 392 30.4
>30 898 69.6
Sex29 missing
Men 464 36.8
Women 794 63.2
Department
Medical 353 27.4
Accident and emergency 71 5.5
Paediatrics 199 15.4
Primary care 176 13.6
Physiotherapy 7 0.5
Occupational therapy 2 0.2
Surgery 26 2.0
Nonclinical/administration/others 456 35.3
Job Title25 missing
Doctor 488 38.6
Allied health 53 4.2
Nurse 673 53.2
Administration 20 1.6
Others 31 2.5
Years of work in health
services18 missing
5 221 17.4
6–10 156 12.3
11–20 324 25.5
>20 571 44.9
Number of patient contacts
per week24 missing
0 75 5.9
1–25 249 19.7
26–50 231 18.2
>50 711 56.2
Seasonal flu vaccination in
the past 3 years20 missing
Ad Hoc Influenza Vaccinationwhether the respondent had received seasonal influenza vacci-
nation in the past 3 years, their perceived risk of contracting
influenza, and how serious they perceived their life would be
affected by influenza. The statistical significance of the associ-
ations was evaluated by Chi-square tests or Fisher exact tests as
appropriate. The independent factors associated with the inten-
tion to receive the additional vaccine were assessed by a binary
logistic regression analysis, using variables with P
values<0.10 in the univariate analyses as covariates. We
performed regression analysis where the variable selection
procedure adopted was stepwise. We have used forward step-
wise technique since it is best suited for studies where the
sample size is not very large. All P values<0.05 were regarded
as statistically significant in the final regression model.
RESULTS
Progress of Vaccination Campaign
The vaccination campaign was started on May 8, 2015,
after the current survey was completed. The 1st group of
subjects to receive the additional vaccine includes the elderly
in long-stay residential care homes although onMay 20, 2015, it
was extended to the community elderly aged 85 years or
above.11 The campaign is still ongoing at the time of writing.
(http://www.chp.gov.hk/en/view_content/39442.html). As of
February, 2016, the findings of this campaign are still in the
analysis stage and will be disseminated very soon.
Participant Characteristics
A total of 1296 completed questionnaires were received,
including 992 hard copies and 304 via the on-line platform. The
response rate from public hospitals was 37.2%, whereas the
response rate from e-invitation was 25.3%. The survey covered
public hospitals in various geographically dispersed districts,
with at least 1 department involved in each hospital. The
characteristics of the respondents were similar to the distri-
bution of the healthcare manpower resources in Hong Kong.
The demographic characteristics of the participants are shown
in Table 1. Among them, 72.6% strongly agreed or agreed that
in general, seasonal influenza vaccine is effective, and 86.3%
strongly agreed or agreed that it is safe.
Opinion on the Additional Ad Hoc Vaccine
The majority of the respondents agreed or strongly agreed
that the vaccine would bring benefit to the society (88.9%), save
lives (86.7%), reduce medical expenses (76.3%), satisfy public
expectations (82.8%), and increase awareness of influenza
vaccines (86.1%) (Table 2). Yet more than half of the partici-
pants were concerned that the virus strain in the new vaccine
might not be the same virus that would circulate in the coming
summer (83.5%); that people who received the new vaccines in
April or May this year might not be certain whether they should
receive the next vaccination in October to December (66.0%);
that the vaccine uptake rate might be low (61.3%); that most
people already had flu attacks in the previous winter (55.1%);
and that the additional vaccine might have more side effects
(51.3%) (Table 2).
Perceived Priority Groups for the Additional Ad
Hoc Vaccine
Medicine  Volume 95, Number 19, May 2016Turning to the perceived vaccine recipient group which
should be given priority if the government has limited doses, the
top priority selected was the elderly aged 65 years with
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.chronic medical conditions (89.2%), followed by the elderly
living in residential care homes (87.4%), long-stay residents of
institutions for the disabled (80.7%), the elderly aged65 years
(79.3%), and healthcare workers in residential care homes
(78.5%), whereas pregnant women were regarded as lowest
priority (30.8%) (Table 3). Most respondents strongly agreed or
agreed that doctors (71%), nurses (75.9%), and allied health
professionals (54.9%) should be given a top priority for receiv-
ing the new vaccine. Only 9.7% held the opinion that healthcare
workers in administration should receive a high priority.
Intention to Accept Additional Ad Hoc Vaccine
Only 401 respondents (31.8%) expressed their intention to
accept the additional ad hoc vaccine (Table 4), and a signifi-
cantly higher proportion would recommend the new vaccine to
their patients (81.4%) and family members (70.3%) who were at
high risk for severe influenza (Figure 1). Far fewer respondents
Yes 652 51.3
No 618 48.7would recommend the additional vaccine to their patients
(20.3%) and family members (16.9%) who were not at high
risk for severe infection. Even in healthcare workers who
www.md-journal.com | 3
TABLE 2. The Opinions of Healthcare Workers on the Additional Ad Hoc Influenza Vaccination

Statement Strongly Agree Agree Disagree Strongly Disagree
Perceived benefits
It brings benefits to Hong Kong 200 (15.6) 937 (73.3) 130 (10.2) 11 (0.9)
It saves lives 178 (14.0) 926 (72.7) 159 (12.5) 11 (0.9)
It reduces medical expenses 169 (13.3) 802 (63.0) 270 (21.2) 33 (2.6)
It satisfies public expectations 198 (15.6) 855 (67.2) 207 (16.3) 13 (1.0)
It increases awareness of flu vaccine 190 (14.9) 905 (71.2) 165 (13.0) 11 (0.9)
Perceived barriers
It disturbs normal vaccination schedule 65 (5.1) 512 (40.4) 646 (51.0) 43 (3.4)
People vaccinated in April/May, not sure what to do in
the next vaccination round in October–December
133 (10.5) 705 (55.5) 404 (31.8) 28 (2.2)
Summer peak may not occur 61 (4.8) 550 (43.4) 618 (48.7) 39 (3.1)
It may not be the same virus in summer 168 (13.3) 889 (70.2) 198 (15.6) 11 (0.9)
Additional vaccination might weaken the efficacy of
previous vaccination
33 (2.6) 315 (25.2) 807 (64.5) 96 (7.7)
Additional vaccination might create more side effects 62 (4.9) 582 (46.4) 550 (43.9) 60 (4.8)
The uptake rate will be low 91 (7.3) 677 (54.0) 455 (36.3) 30 (2.4)
Most people already had flu in winter 84 (6.6) 613 (48.5) 530 (41.9) 38 (3.0)
Influenza vaccines do not work 43 (3.4) 351 (27.8) 740 (58.6) 128 (10.1)

The new influenza vaccine contains the Southern Hemisphere vaccine to certain groups of people in April/May 2015 to prevent influenza infection
Wong et al Medicine  Volume 95, Number 19, May 2016perceived themselves as likely to contract influenza or those
who perceived the personal effect of influenza to be serious, a
majority (61.2% and 55.3%, respectively) still did not plan to
receive vaccination themselves. From the univariate analysis,
in summer.older age, male sex, working in a specialty other than surgery
and emergency, engagement in administration or being a
medical doctor, having received influenza vaccination in the
TABLE 3. Perceived Priority of Subjects Who Should Receive the
Statement Very High Priori
Recommended priority of subjects for vaccination
Children 6 months to <6 years 205 (16.5)
Elderly 65 years 351 (27.9)
Elderly living in residential care homes 559 (44.4)
Long-stay residents of institutions for the
disabled
440 (35.0)
Elderly 65 years with chronic medical
problems
612 (48.5)
Persons with chronic medical problems
regardless of age
199 (15.9)
Pregnant women 96 (7.6)
Healthcare workers in clinical areas 162 (12.9)
Healthcare workers in contact with patients
high-risk for severe influenza
424 (33.7)
Healthcare workers in residential care homes 185 (14.7)
Healthcare workers in institutions for the
disabled
161 (12.8)
Job duty of healthcare workers
Doctors 283 (22.5)
Nurses 387 (30.7)
Allied health 171 (13.6)
Administration 25 (2.0)
4 | www.md-journal.compast 3 years, and the perception that they were likely to contract
the virus and that the infection would seriously affect their daily
living were significantly associated with intention to accept the
vaccine (Table 4). From the multivariate regression analysis,
healthcare workers in primary care (adjusted odds ratio
[AOR]¼ 1.66, 95% CI 1.07–2.58, P¼0.024), doctors
(AOR¼ 0.65, 95% CI 0.44–0.94, P¼ 0.022 for nondoctors),
Additional Ad Hoc Influenza Vaccine
ty High Priority Medium Priority Not Recommended
528 (42.4) 388 (31.2) 123 (9.9)
647 (51.4) 224 (17.8) 37 (2.9)
541 (43.0) 135 (10.7) 24 (1.9)
575 (45.7) 214 (17.0) 29 (2.3)
514 (40.7) 111 (8.8) 25 (2.0)
595 (47.7) 394 (31.6) 60 (4.8)
291 (23.2) 524 (41.7) 345 (27.5)
470 (37.3) 555 (44.1) 72 (5.7)
564 (44.8) 237 (18.8) 34 (2.7)
525 (41.7) 495 (39.3) 55 (4.4)
502 (39.9) 530 (42.1) 65 (5.2)
611 (48.5) 311 (24.7) 55 (4.4)
569 (45.2) 264 (21.0) 39 (3.1)
518 (41.3) 490 (39.0) 76 (6.1)
96 (7.7) 374 (30.0) 753 (60.3)
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 4. Univariate Association of Variables Influencing the Intention to Accept the Additional Ad Hoc Influenza Vaccine
Intention to Accept Additional Vaccine
Variable Total Yes No P Value of Difference

Age, years
30 392 (30.4) 104 (28.3) 263 (71.7) 0.03
>30 898 (69.6) 297 (35.7) 534 (64.3)
Sex
Men 456 (37.0) 165 (38.5) 264 (61.5) 0.008
Women 777 (63.0) 228 (30.6) 517 (69.4)
Department
Medical 341 (27.9) 98 (30.3) 225 (69.7) <0.001
Accident and Emergency 70 (5.7) 15 (22.1) 53 (77.9)
Pediatrics 196 (16.1) 78 (41.3) 111 (58.7)
Primary care 171 (14.0) 68 (41.0) 98 (59.0)
Physiotherapy 7 (0.6) 3 (42.9) 4 (57.1)
Occupational therapy 2 (0.2) 2 (100) 0 (0.0)
Surgery 26 (2.1) 4 (15.4) 22 (84.6)
Nonclinical/administration/
others
407 (33.3) 121 (31.8) 259 (68.2)
Job Title25 missing
Doctor 480 (38.8) 199 (43.5) 258 (56.5) <0.001
Allied health 53 (4.3) 17 (35.4) 31 (64.6)
Nurse 657 (53.1) 157 (25.0) 470 (75.0)
Administration 20 (1.6) 8 (44.4) 10 (55.6)
Others 28 (2.3) 12 (44.4) 15 (55.6)
Years of work in health
services18 missing
5 217 (17.4) 68 (33.0) 138 (67.0) 0.99
6–10 154 (12.4) 47 (32.2) 99 (67.8)
11–20 319 (25.6) 98 (32.3) 205 (67.7)
>20 555 (44.6) 181 (34.2) 348 (65.8)
Number of patient contacts
per week24 missing
0 73 (5.9) 22 (35.5) 40 (64.5) 0.18
1–25 243 (19.6) 76 (32.8) 156 (67.2)
26–50 230 (18.5) 73 (33.8) 143 (66.2)
>50 694 (56.0) 223 (33.3) 447 (66.7)
Seasonal flu vaccination in the
past 3 years20 missing
Yes 637 (51.2) 341 (55.4) 275 (44.6) <0.001
No 606 (48.8) 55 (9.7) 511 (90.3)
Perceived risk of contracting influenza
Very likely 70 (5.6) 50 (74.6) 17 (25.4) <0.001
Likely 668 (53.1) 247 (38.8) 389 (61.2)
Unlikely 486 (38.6) 97 (21.1) 362 (78.9)
Very unlikely 34 (2.7) 6 (17.6) 28 (82.4)
Perceived severity of effect of flu
to own life
Very serious 27 (2.1) 19 (70.4) 8 (29.6) <0.001
Serious 280 (22.3) 119 (44.7) 147 (55.3)
Little serious 822 (65.4) 225 (28.8) 556 (71.2)
Not serious 127 (10.1) 36 (30) 84 (70)

x2 test or Fisher exact tests for variables with any cell<5. Values are numbers (percentages) of respondents unless stated otherwise. The values in
bold represented those with P< 0.10, which were selected as variables in the multivariate regression analysis.
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FIGURE 1. Acceptability of the additional ad hoc vaccine by the
Wong et alhaving received influenza vaccination in the past 3 years
(AOR¼ 0.09, 95% CI 0.07–0.13, p<0.001 for nonreceivers),
higher perceived risk of contracting influenza (AOR¼ 0.55,
95% CI 0.41–0.76, P<0.001 for low perceived risk), and
higher perceived severity of the negative effect of flu on one’s
own life (AOR¼ 0.48 95% CI 0.34–0.66, P<0.001 for low
perceived severity) were associated with intention to accept the
additional vaccine (Table 5). The findings from forward step-
wise procedures were statistically similar to those generated by
entering all variables into the regression model, showing that
the findings were scientifically robust.
healthcare workers and their recommendation to their patients
and family members.Only 22.8% of respondents agreed that influenza vaccina-
tion should be compulsory for all health workers without
contraindications of the vaccine. A total of 86.2% regarded
TABLE 5. Multiple Logistic Regression Model for Intention to Ac
Variable Adjusted OR
Age, years
30 1
>30 0.97 (0.69
Sex
Men 1
Women 1.17 (0.84
Department
Medical 1
Accident and emergency 0.95 (0.65
Paediatrics 1.04 (0.49
Primary care 1.66 (1.07
Job title
Doctor 1
Nurse 0.65 (0.44
Others 1.27 (0.71
Seasonal flu vaccination in the past 3 years
Yes 1
No 0.09 (0.07
Perceived risk of contracting influenza
Likely or very likely 1
Unlikely or very unlikely 0.55 (0.41
Perceived severity of effect of flu to own life
Serious or very serious 1
Not or little serious 0.48 (0.34
The values in bold represented those with P<0.05. CI¼ confidence int
P< 0.05.
6 | www.md-journal.comoriginal duty (instead of redeployment to duty with no patient
contact) to be appropriate during the influenza season for
healthcare workers who do not receive influenza vaccine.
Compared with respondents who supported original duty,
higher proportion of those who regarded redeployment as
appropriate agreed that influenza vaccination should be com-
pulsory (34.5% vs 20.9%, P<0.001).
DISCUSSION
Statement of Principal Findings
Healthcare professionals had a low level of intention to
accept the additional ad hoc vaccination despite a high pro-
portion perceiving its benefits to individuals, the healthcare
system, and the society. In addition, a similarly high proportion
had concerns about reduced vaccine effectiveness due to change
in predominant viral strains in the coming season, disturbing the
usual annual vaccination schedule and low uptake leading to
devaluation of the program. A significantly higher proportion of
healthcare workers were, however, willing to recommend the
additional vaccine to family members and patients at high risk
for severe infection. Also, more than half of the healthcare
workers who perceived themselves as at risk of contracting
influenza or perceived severity of the infection did not intent to
receive the vaccine. Most of the respondents assigned a higher
priority of the new vaccine to the elderly especially those with
chronic medical conditions or living in institutions, and to
doctors and nurses. Of note, pregnant women were regarded
Medicine  Volume 95, Number 19, May 2016as the lowest priority among the risk groups provided. Health-
care workers who previously received influenza vaccination,
perceived higher risk of contracting influenza, and perceived
cept the Additional Ad Hoc Influenza Vaccination
(95% CI) P Value of Difference
0.85
to 1.36)
0.64
to 1.65) 0.36
0.11
to 1.39) 0.80
to 2.19) 0.93
to 2.58) 0.024
0.014
to 0.94) 0.022
to 2.25) 0.42
to 0.13) <0.001
to 0.76) <0.001
<0.001
to 0.66)
erval, OR¼ odds ratio.
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greater severity of the negative effect of flu on their own life
were independently associated with acceptability of the
additional vaccine.
Explanation of Findings and Comparison With
Published Literature
Worldwide, influenza vaccination campaigns are con-
ducted once a year. The unique seasonality of influenza in
subtropical regions with more than 1 peak in a year provides an
opportunity to administer an additional vaccine with the latest
composition to combat newly emerged antigenically drifted
variants. To the best of our knowledge, the attempt of the Hong
Kong Government is the first of its kind, and there is currently
no study that has explored the level of acceptability of the ad
hoc additional influenza vaccination under such circumstances.
Most of the respondents were females, which is compatible with
the female dominance in the nursing profession. The response
rate to this survey invitation was nevertheless, low. There are a
number of reasons which could explain this, including the busy
schedules of healthcare professionals, the absence of incentives
built in this present survey, and the possibility of multiple study
invitations from other researchers sent to the prospective study
participants – where the current round of survey invitations
might not be perceived by some as having an immediate
relevance to their clinical practice.
The results show that the willingness of healthcare pro-
fessionals to accept the ad hoc additional vaccine was similar to
our previous study on vaccination against prepandemic influ-
enza in Hong Kong.11 The overall willingness to receive H5N1
vaccine was 28.4% in 2009 among healthcare workers, which is
similar to the current figure (31.8%). Somewhat higher accep-
tance levels of pandemic vaccine have been reported among
health care workers in France (36.5%),16 UK hospitals
(63.4%),17 and frontline healthcare workers in Shropshire
County’s general practices (83.9%),18 but lower as shown in
another local study conducted among nurses in Hong Kong
(13.3%).19 The relatively low acceptance rate in Hong Kong
could be related to the high proportion (83.5%) of respondents
perceiving that the viral strain may be different in the coming
season, which makes the additional vaccine relatively redun-
dant and not cost-effective. Several studies have reported that
safety concerns about a new vaccine20 and the difficulty to
reconcile conflicting evidence about the vaccine21–23 as import-
ant barriers. Turning to the factors associated with the intention
to accept the additional vaccine, the Health Belief Model
(HBM) could explain the relationship between vaccine accept-
ability and perceived risk of contracting influenza as well as
perceived severity of influenza.24 Since the efficacy, safety
profile, and cost-benefit of the additional vaccine has not been
fully evaluated, recommendations to encourage healthcare
workers to take the vaccine will need to be further consolidated.
We found that primary care physicians had a significantly
higher acceptance rate than physicians of other specialties,
and thus could play a key role in mobilizing colleagues working
in other specialties. Our results indicate that one could invest
more resources to improve acceptance among healthcare
workers as the majority of them believe that influenza vaccine
saves lives (86.7%) and reduces medical expenses (76.3%).
This study highlighted that 80% to 90% of healthcare workers
supported vaccination for high-risk patients, in contrast to low
Medicine  Volume 95, Number 19, May 2016level of personal acceptance even when perceived risk of
infection and severity of impact were high. This study pointed
out that such discordance that may be a reasonable target for
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.further strategies to improving vaccination campaign accept-
ability. Protecting healthcare workers may be an important
measure to prevent in-hospital spread of infection in the face
of influenza outbreak. Therefore, improving vaccine acceptance
among high-risk healthcare professionals should be a priority in
enhancing update of vaccination program.
Strengths and Weaknesses of the Present Study
To our knowledge this is the first large-scale study which
evaluated the acceptability of ad hoc additional influenza vacci-
nation among healthcare workers at a time where antigenic drift
occurs. The study provides data on the factors associated with
uptake and the perception of healthcare workers on the at-risk
groups where vaccination should be a high priority. The sample
size is adequately powered. However, some limitations should be
addressed. First, we evaluated the acceptability of the healthcare
workers at a relatively early stage of the programme, and there
exists the possibility that their opinions and perception may
change overtime. In addition, the response rate of the survey
was modest, and thus a biased sample might have been recruited.
Hence, a major limitation of this study included the inability of
the researchers to characterize the nonresponders, since the only
information we have for these nonresponders was their contact
methods. Nevertheless, there are no concrete, plausible expla-
nations why the responders and nonresponders should be differ-
ent with respect to their intention to accept ad hoc influenza
vaccines. Furthermore, this acceptability survey captured
opinions of healthcare workers but not what they would practice
in reality. Hence, future cohort studies should be performed to
assess the actual uptake rate when the vaccine is available for
use. Finally, there might be more in-depth barriers to receiving
the additional vaccine among the healthcare workers, and these
are better studied by qualitative evaluations.
Conclusions: Clinical and Policy
Recommendations
The findings from this study could inform public health
practitioners and policy-makers to design and implement plans
for additional influenza vaccination in years where a significant
antigenicdrift hasoccurred.The factors found tobeassociatedwith
vaccine nonacceptance and the perception of the healthcare
workers on risk groups which should receive higher priority for
vaccination provides useful information for programme planning.
We recommend future qualitative studies to explore in-
depth reasons of the low uptake rate, the attitude and perception
of the significance of antigenic drift, and interventional strat-
egies which could enhance vaccine acceptability should be
devised and evaluated in the future.
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